📣 VC round data is live. Check it out!
- Public Comps
- FluoGuide
FluoGuide Valuation Multiples
Discover revenue and EBITDA valuation multiples for FluoGuide and similar public comparables like Senzime, Medicalgorithmics, Applied BioCode, Vuno and more.
FluoGuide Overview
About FluoGuide
FluoGuide AS is a clinical-stage biotechnology company focused on developing drugs that maximize surgical outcomes by making cancer fluorescent. Its technology includes uPAR, which is part of a proteolytic system, and FG001, a product injected into the patient's vein prior to surgery.
Founded
2018
HQ

Employees
8
Website
Financials (LTM)
EV
$72M
Valuation Multiples
Start free trialFluoGuide Financials
FluoGuide reported last 12-month revenue of - and negative EBITDA of ($7M).
In the same LTM period, FluoGuide generated - in gross profit, ($7M) in EBITDA losses, and had net loss of ($7M).
Revenue (LTM)
FluoGuide P&L
In the most recent fiscal year, FluoGuide reported revenue of - and EBITDA of ($6M).
FluoGuide is unprofitable as of last fiscal year, with EBITDA margin of - and net margin of -.
Financial data powered by Morningstar, Inc.
FluoGuide Stock Performance
FluoGuide has current market cap of $78M, and enterprise value of $72M.
Market Cap Evolution
FluoGuide's stock price is $4.74.
FluoGuide share price decreased by 0.8% in the last 30 days, and increased by 8.8% in the last year.
FluoGuide has an EPS (earnings per share) of $-0.38.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $72M | $78M | -0.8% | -0.8% | 20.5% | 8.8% | $-0.38 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialFluoGuide Valuation Multiples
FluoGuide trades at (10.7x) EV/EBITDA.
FluoGuide Financial Valuation Multiples
As of June 2, 2026, FluoGuide has market cap of $78M and EV of $72M.
FluoGuide has a P/E ratio of (11.4x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified FluoGuide Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


FluoGuide Margins & Growth Rates
FluoGuide grew EBITDA by 21% in the last fiscal year.
FluoGuide Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
FluoGuide Operational KPIs
FluoGuide's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.8M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
FluoGuide Competitors
FluoGuide competitors include Senzime, Medicalgorithmics, Applied BioCode, Vuno, Agfa-Gevaert, AnteoTech, Nexstim, Aiforia, BioStem Technologies and Pentixapharm Holding.
Most FluoGuide public comparables operate across Medical Devices, Medical Imaging & Diagnostics, BioTech, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 6.2x | 5.3x | (6.5x) | (8.6x) | |||
| 12.3x | 7.7x | (24.7x) | 242.9x | |||
| 4.2x | - | (13.8x) | - | |||
| 2.6x | - | (24.4x) | - | |||
| 0.2x | 0.2x | 3.1x | 3.1x | |||
| 107.6x | 116.4x | (20.2x) | (32.2x) | |||
| 5.9x | 5.5x | 35.4x | 31.9x | |||
| 16.8x | 13.7x | (9.9x) | (12.1x) | |||
This data is available for Pro users. Sign up to see all FluoGuide competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout FluoGuide
| When was FluoGuide founded? | FluoGuide was founded in 2018. |
| Where is FluoGuide headquartered? | FluoGuide is headquartered in Denmark. |
| How many employees does FluoGuide have? | As of today, FluoGuide has over 8 employees. |
| Is FluoGuide publicly listed? | Yes, FluoGuide is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of FluoGuide? | FluoGuide trades under FLUO ticker. |
| When did FluoGuide go public? | FluoGuide went public in 2019. |
| Who are competitors of FluoGuide? | FluoGuide main competitors include Senzime, Medicalgorithmics, Applied BioCode, Vuno, Agfa-Gevaert, AnteoTech, Nexstim, Aiforia, BioStem Technologies, Pentixapharm Holding. |
| What is the current market cap of FluoGuide? | FluoGuide's current market cap is $78M. |
| Is FluoGuide profitable? | No, FluoGuide is not profitable. |
| What is the current EBITDA of FluoGuide? | FluoGuide has negative EBITDA and is not profitable. |
| What is the current EV/EBITDA multiple of FluoGuide? | Current EBITDA multiple of FluoGuide is (10.7x). |
| How many companies FluoGuide has acquired to date? | FluoGuide hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies FluoGuide has invested to date? | FluoGuide hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to FluoGuide
Lists including FluoGuide
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.